SCHEMBL24088009

SCHEMBL24088009

N#Cc1c(-c2cccs2)cc(=O)[nH]c1SCc1cncc(-c2noc(=O)[nH]2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 6/20 0.55
▸ KDM4E B2RXH2 7/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 5/20 0.40
▸ GLA P06280 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ PIM1 P11309 2/20 0.39
▸ NPSR1 Q6W5P4 5/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ PRNP P04156 2/20 0.37
▸ RXFP1 Q9HBX9 2/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ SAE1 Q9UBE0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24088014 0.90 ACMSD (0.68) ACMSDKDM4EALDH1A1HPGDGLA
SCHEMBL24087895 0.87 ACMSD (0.45) ACMSDALDH1A1HPGDMEN1KMT2A
SCHEMBL24088142 0.87 ACMSD (0.48) ACMSDNPSR1MEN1KMT2APRNP
SCHEMBL26847371 0.81 KDM4E (0.39) ACMSDKDM4EALDH1A1HPGDGLA
SCHEMBL24087882 0.77 ACMSD (0.55) ACMSDKDM4EALDH1A1HPGDMEN1
SCHEMBL24088104 0.76 ACMSD (0.59) ACMSDKDM4EMEN1KMT2ACYP2C19
SCHEMBL26847199 0.75 ACMSD (0.48) ACMSDKDM4EALDH1A1HPGDGAA
SCHEMBL20340083 0.74 ACMSD (0.49) ACMSDKDM4EALDH1A1HPGDGLA
SCHEMBL24087958 0.73 ACMSD (0.46) ACMSDKDM4EALDH1A1HPGDGAA
SCHEMBL23850235 0.73 ACMSD (0.64) ACMSDKDM4EALDH1A1HPGDPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885KDM4E 1110/4885ALDH1A1 171/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885KDM4E 1110/4885ALDH1A1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback